Navigation Links
Elsevier selected to publish Cytotherapy: The Journal of Cell Therapy
Date:1/7/2013

Amsterdam, January 7, 2013 Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce that the International Society for Cellular Therapy (ISCT) has selected Elsevier to publish Cytotherapy: The Journal of Cell Therapy effective January 2013.

"Elsevier presented ISCT with unsurpassed reach into the global medical community, top class publishing services, and significant experience in this field. We are extremely confident that our collaboration with Elsevier will not only help Cytotherapy grow for the benefit of our members and readers, but also for the benefit of all scientists, technologists, regulators, manufacturing experts and others dedicated to translational development of safe and effective cell therapies," said ISCT President, Kurt Gunter, MD, FASCP.

Cytotherapy is a highly influential publication in the mainstream of the rapidly expanding field of cell-based treatments for cancer, degenerative disorders, immunotherapy and stem cell transplantation. Cytotherapy publishes cutting edge findings, clinical trials of cell-based therapies, and news and opinion on all aspects of these disciplines. The journal focuses especially on the practical translation of scientific developments in the laboratory into clinical practice. Cytotherapy is an essential global resource for clinical researchers, oncologists, hematologists, doctors, and regulatory experts involved in cell processing and therapy.

Senior Editor of Cytotherapy, John Barrett, MD, commented, "What matters is ensuring that new peer-reviewed treatments, developments, and studies reach as many specialists working with cell therapies as possible. In this, I believe Elsevier offers an unrivaled opportunity to help the journal achieve this goal."

Glen Campbell, Executive Vice President at Elsevier added, "Cytotherapy is an established and reputable jou
'/>"/>

Contact: Brant Emery
b.emery@elsevier.com
31-204-853-310
Elsevier
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Elsevier launches new open access journal: Journal of Pediatric Surgery Case Reports
2. Elsevier launches new open access journal -- Epilepsy & Behavior Case Reports
3. Elsevier launches new open access journal: Leukemia Research Reports
4. Elsevier launches new journal: Health Care: The Journal of Delivery Science and Innovation
5. Elsevier congratulates its British Medical Association award winning medical authors and editors
6. Elsevier launches new journal: Performance Enhancement & Health
7. Elsevier announces publishing the Journal of Hospitality, Leisure, Sport and Tourism Education
8. Elsevier, SVS announce 2013 launch of Journal of Vascular Surgery: Venous and Lymphatic Disorders
9. Elsevier organizes label-free technologies conference
10. Easy On Hold Selected by John Deere Dealer Group to Present On Hold Messaging Workshop at Trade Show in February
11. Mangos' Work Selected as Communication Arts Webpick of the Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Mesa, Arizona (PRWEB) May ... Ag Ventures, Inc. (MAV), an investor backed Colorado ... Arizona based Phoenician Engineering subsidiary three times since ... recently achieved profitability from operations, within one year ... at the end of 2014 to over 500 ...
(Date:5/6/2015)... Established by the Arthritis Foundation, the month of ... Americans who suffer from arthritis. Many who battle this ... symptoms. Medicationdiscountcard.com is proud to offer a prescription ... costs of these necessary prescriptions. , Non-Steroidal Anti-Inflammatory Drugs ... and inflammation in the joints associated with arthritis. Certain ...
(Date:5/6/2015)... Most people in the United States will need at ... age 65. But less than half of people in their ... about it, reports the May 2015 Harvard Health Letter ... is losing control over the care they'll receive. "Many people ... a professor of health care policy at Harvard Medical School. ...
(Date:5/6/2015)... Novodiax announced today that they will ... with Ed Begley Jr., airing via Discovery Channel ... , This segment will explore Novodiax, a company ... will learn about Novodiax’s polymer detection system-based Direct ... scenes to investigate how, based on this technology, ...
(Date:5/6/2015)... A recent National Eye Institute (NEI) ... age, is fully endorsed by fresh water advocate Sharon ... Water® radio show. Kleyne notes, however, that the report ... each day. As Founder and Chairman of Bio-Logic Aqua ... Kleyne has extensive knowledge of vision care, dry eye, ...
Breaking Medicine News(10 mins):Health News:Cannibus Industry Start-Up Reaches Profitability While Expanding Its Proprietary Ancillary Medical Marijuana Product IP Portfolio 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 3Health News:Start Planning Now for Long-Term Care, from the May 2015 Harvard Health Letter 2Health News:Novodiax to Be Featured in Upcoming Episode of Innovations TV Series 2Health News:National Eye Institute’s Eye Care as You Age report endorsed by fresh water advocate Sharon Kleyne – with one addition 2Health News:National Eye Institute’s Eye Care as You Age report endorsed by fresh water advocate Sharon Kleyne – with one addition 3
... economy has been "seizing" uncontrollably. Now a Tel Aviv ... economic downturn with the uncontrolled spasms of an epileptic ... the origins of the disaster. In a recent ... Ben-Jacob of Tel Aviv University,s School of Physics and ...
... released online today, a majority of Americans, including most African ... just as other cigarette flavorings have now been banned by ... African American smokers and 24 percent of white smokers smoke ... by the Center for Child and Adolescent Health Policy at ...
... , THURSDAY, May 12 (HealthDay News) -- Italian researchers ... may actually suffer from a psychological condition known as ... is deficient in the enzyme lactase, which breaks down ... bloating, gas, gut pain and nausea when they eat ...
... Researchers at the Stanford University School of Medicine ... naturally occurring "tumor-suppressor" protein works. The separation of these ... could enhance efforts to develop treatment approaches that ... The protein, p53, is mutated or missing in ...
... May 12 (HealthDay News) -- Mind-body therapies such as yoga, ... in mainstream medicine, according to a new study. ... and that number is rising, the researchers noted. They found ... therapy was referred to the treatment by a medical provider. ...
... Amanda Gardner HealthDay Reporter , WEDNESDAY, May 11 ... adults with attention-deficit hyperactivity disorder (ADHD), or the parents of ... finding one that carries the prescription they need to manage ... vary, but much of the focus has been on Adderall ...
Cached Medicine News:Health News:Diagnosing 'seizures' in the US economy 2Health News:African Americans and the general public support banning menthol in cigarettes 2Health News:Lactose Intolerance May Sometimes Be in the Head, Not the Gut 2Health News:Stanford discoveries about tumor-suppressing protein could help to reduce treatment side effects 2Health News:Stanford discoveries about tumor-suppressing protein could help to reduce treatment side effects 3Health News:Doctors Prescribing Meditation, Yoga More Often 2Health News:ADHD Drug Shortage Has Patients, Parents Scrambling 2Health News:ADHD Drug Shortage Has Patients, Parents Scrambling 3
(Date:5/6/2015)... --  Sigma-Aldrich Corporation (NASDAQ: SIAL ) a leading ... $50,000 product donation to the Reproducibility Project: Cancer ... from recent high-impact papers in the field of cancer ... research marketplace Science Exchange , the non-profit ... eLife. The goal of the project is ...
(Date:5/6/2015)... 2015 First programme ... and rilpivirine   ViiV Healthcare ... clinical trial programme to evaluate the safety and ... ) as maintenance therapy for adult patients with ... studies evaluating 48 week viral suppression with a ...
(Date:5/5/2015)... BARCELONA, Spain , May 6, 2015 ... and aspires to lead the European market in the ... Through this alliance ECUPHAR acquires all the assets ... the new organization in the coming weeks. Being both ... not been disclosed.      (Photo: http://photos.prnewswire.com/prnh/20150506/743274 ...
Breaking Medicine Technology:Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 2Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 2ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 5ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 6ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 7ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 8ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 9ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 10ECUPHAR Enters the Spanish and Southern European Markets Through ESTEVE 2
... of its ongoing,efforts to develop research tools that ... disease, The Michael J. Fox,Foundation announced the launch ... the Foundation seeks to drive the creation,and testing ... with a personal,computer and an Internet connection to ...
... March 19 FluoroPharma Inc., a company,developing breakthrough ... (PET) market, announced commencement of Phase,I clinical trials ... the proposed studies. The Phase I trial is ... safety, distribution and dosimetry,of BFPET as a PET ...
Cached Medicine Technology:New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinson's Clinical Trials 2FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2
All-natural porcine collagen can be used in open or laparoscopic placement....
... SBI RingFix is a modular external fixation ... large variety of clinical needs. Originally marketed ... has a successful 20 year history of ... Developed around the principles of the Ilizarov ...
... The six models of Thermo Scientific ... mL to 60 mL with very high ... careful design of all components. The Finnpipette ... the extensive Thermo Scientific Finnpipette manual liquid ...
... collection benefits from innovative research in materials ... such as the aerospace and automotive industry, ... and the footwear and textile industry. , ... in the Carrera sunglasses collection to create ...
Medicine Products: